- Home
- INO vs ME Comparison
INO vs ME Comparison
Compare INO & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- ME
- Stock Information
- Founded
- INO 1979
- ME 2006
- Country
- INO United States
- ME United States
- Employees
- INO N/A
- ME N/A
- Industry
- INO Medical/Dental Instruments
- ME Precision Instruments
- Sector
- INO Health Care
- ME Health Care
- Exchange
- INO Nasdaq
- ME Nasdaq
- Market Cap
- INO 110.7M
- ME 113.9M
- IPO Year
- INO 1998
- ME N/A
- Fundamental
- Price
- INO $1.96
- ME $3.24
- Analyst Decision
- INO Buy
- ME Hold
- Analyst Count
- INO 6
- ME 1
- Target Price
- INO $16.33
- ME $9.40
- AVG Volume (30 Days)
- INO 1.2M
- ME 393.2K
- Earning Date
- INO 11-14-2024
- ME 02-05-2025
- Dividend Yield
- INO N/A
- ME N/A
- EPS Growth
- INO N/A
- ME N/A
- EPS
- INO N/A
- ME N/A
- Revenue
- INO $203,413.00
- ME $193,260,000.00
- Revenue This Year
- INO N/A
- ME $21.93
- Revenue Next Year
- INO $2,290.97
- ME $17.31
- P/E Ratio
- INO N/A
- ME N/A
- Revenue Growth
- INO N/A
- ME N/A
- 52 Week Low
- INO $1.91
- ME $2.66
- 52 Week High
- INO $14.75
- ME $19.38
- Technical
- Relative Strength Index (RSI)
- INO 12.76
- ME 38.88
- Support Level
- INO $3.96
- ME $3.26
- Resistance Level
- INO $4.08
- ME $3.50
- Average True Range (ATR)
- INO 0.25
- ME 0.35
- MACD
- INO -0.19
- ME 0.04
- Stochastic Oscillator
- INO 1.85
- ME 12.26
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.